Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 6,307 $ 13,172
Accounts receivable 38 0
Other receivables 6 1,919
Inventory, net 18 20
Prepaid expenses and other current assets 1,135 1,290
Restricted cash, current portion 15 15
Total current assets 7,519 16,416
Property and equipment, net 2,176 2,411
Goodwill 14,409 14,409
Restricted cash, net of current portion 131 131
Total assets 24,235 33,367
Current liabilities:    
Accounts payable 751 2,882
Deferred revenue 0 88
Accrued expenses and other current liabilities 7,588 13,214
Notes payable, current 14,115 5,930
Total current liabilities 22,454 22,114
Notes payable, non-current 0 13,486
Royalty obligation 2,000 2,000
Deferred tax liability, net 156 141
Derivative liability 5,050 4,830
Other long-term liabilities 1,544 1,711
Total liabilities 31,204 44,282
Stockholders’ deficit:    
Common stock—$0.001 par value; 200,000,000 shares authorized at June 30, 2023 and December 31, 2022; 14,036,940 and 9,430,535 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 14 9
Additional paid-in capital 314,755 292,900
Accumulated deficit (321,738) (303,824)
Total stockholders’ deficit (6,969) (10,915)
Total liabilities and stockholders’ deficit $ 24,235 $ 33,367